Inovio Defends Virus Vaccine Claims In Bid To Nix Stock Suit
Inovio Pharmaceuticals Inc. said Thursday that it has been entirely upfront with investors about its efforts to develop and produce a COVID-19 vaccine, contrary to the claims of a securities suit...To view the full article, register now.
Already a subscriber? Click here to view full article